Study of Nab-Paclitaxel and Gemcitabine With or Without Tocilizumab in Pancreatic Cancer Patients

Study ID
NCT02767557

Study type
Interventional

Study phase
Phase 2

Study status
Completed

Trial Acronym

PACTO

Trial Summary

This is a multicenter center, 2-arms prospective randomized phase II trial which evaluates whether tocilizumab with gemcitabine/nab-paclitaxel is more effective than gemcitabine/nab-paclitaxel.

More informations

Trial Starting Date

Jan 26,2017

Requirements

Gender All
Minimum age 18 Years
Maximum age N/A

Enrollement Limit

147